Pneumonia Caused by Methicillin‐ResistantStaphylococcus aureus
Top Cited Papers
Open Access
- 1 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (S5), S378-S385
- https://doi.org/10.1086/533594
Abstract
A recent increase in staphylococcal infections caused by methicillin-resistant Staphylococcus aureus (MRSA), combined with frequent, prolonged ventilatory support of an aging, often chronically ill population, has resulted in a large increase in cases of MRSA pneumonia in the health care setting. In addition, community-acquired MRSA pneumonia has become more prevalent. This type of pneumonia historically affects younger patients, follows infection with influenza virus, and is often severe, requiring hospitalization and causing the death of a significant proportion of those affected. Ultimately, hospital-acquired MRSA and community-acquired MRSA are important causes of pneumonia and present diagnostic and therapeutic challenges. Rapid institution of appropriate antibiotic therapy, including linezolid as an alternative to vancomycin, is crucial. Respiratory infection–control measures and de-escalation of initial broad-spectrum antibiotic regimens to avoid emergence of resistant organisms are also important. This article reviews the clinical features of, diagnosis of, and therapies for MRSA pneumonia.This publication has 50 references indexed in Scilit:
- Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumoniaEuropean Respiratory Review, 2007
- Direct E-Test (AB Biodisk) of Respiratory Samples Improves Antimicrobial Use in Ventilator-Associated PneumoniaClinical Infectious Diseases, 2007
- Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusClinical Therapeutics, 2006
- Microarray-based characterisation of a Panton–Valentine leukocidin-positive community-acquired strain of methicillin-resistant Staphylococcus aureusClinical Microbiology & Infection, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Methicillin-resistantStaphylococcus aureusNecrotizing PneumoniaEmerging Infectious Diseases, 2005
- Appropriate Antimicrobial Therapy for Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin GenesClinical Infectious Diseases, 2005
- Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patientsThe Lancet, 2002
- Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unitIntensive Care Medicine, 1996
- Pneumonia Complicating Asian InfluenzaBMJ, 1958